LSTA Acquisition: a negative outcome, -21.2%

On July 24, 2026, LISATA THERAPEUTICS, INC. reached its Acquisition. The result was a negative outcome, and the stock moved -21.2% in the window around the event. It had already run -34.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.